XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $383,000 | +79.0% | 10,605 | +50.4% | 0.00% | +100.0% |
| Q2 2022 | $214,000 | -37.8% | 7,050 | -36.0% | 0.00% | 0.0% |
| Q4 2021 | $344,000 | +12.8% | 11,014 | -54.7% | 0.00% | -80.0% |
| Q2 2020 | $305,000 | +34.4% | 24,321 | +21.4% | 0.01% | -16.7% |
| Q1 2020 | $227,000 | -46.1% | 20,040 | -37.5% | 0.01% | +100.0% |
| Q4 2019 | $421,000 | -46.4% | 32,077 | -63.2% | 0.00% | -57.1% |
| Q3 2019 | $785,000 | -14.4% | 87,100 | -6.3% | 0.01% | -22.2% |
| Q2 2019 | $917,000 | +181.3% | 92,990 | +189.4% | 0.01% | +200.0% |
| Q1 2019 | $326,000 | – | 32,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |